India  
 
NewsR.in

Moderna Sues Pfizer Over COVID Vaccine Patents

Video Credit: Wibbitz Top Stories - Duration: 01:30s - Published
Moderna Sues Pfizer Over COVID Vaccine Patents

Moderna Sues Pfizer Over COVID Vaccine Patents

Moderna Sues Pfizer , Over COVID Vaccine Patents.

Moderna Sues Pfizer , Over COVID Vaccine Patents.

AP reports that Moderna is suing Pfizer and BioNTech for allegedly copying its technology.

.

On Aug.

26, Moderna said the companies' vaccine, Comirnaty, infringes on patents filed years ago for its own vaccine, Spikevax.

.

On Aug.

26, Moderna said the companies' vaccine, Comirnaty, infringes on patents filed years ago for its own vaccine, Spikevax.

.

Stephane Bancel, Moderna CEO, claims the vaccine developer was first to create the mRNA technology used in the current vaccines.

.

Stephane Bancel, Moderna CEO, claims the vaccine developer was first to create the mRNA technology used in the current vaccines.

.

The company claims to have started developing the technology in 2010, which helped it to quickly manufacture its COVID vaccine.

The technology is vastly different from the way vaccines typically work.

.

AP reports that a Pfizer spokesperson said the company has yet to be served.

Moderna is not requesting for Comirnaty to be removed from the market because of the importance of vaccine access.

The company is also not trying to prevent future sales.

.

We are filing these lawsuits to protect the innovative mRNA technology platform that we pioneered, invested billions of dollars in creating, and patented during the decade preceding the COVID-19 pandemic.

, Stephane Bancel, Moderna CEO, via statement


You Might Like


💡 newsR Knowledge: Other News Mentions

COVID-19 COVID-19 Contagious disease caused by SARS-CoV-2

China respiratory illnesses: Govt monitoring situation in India, risk of similar outbreak ‘ low’

 The Centre has asked all states and Union territories to immediately review public health and hospital preparedness in the wake of a rise in respiratory illness..
IndiaTimes

West Bengal: LoP Suvendu Adhikari writes to ED director, I-T, Health ministry, alleges probe in purchase of PPE kits during Covid pandemic

 Suvendu Adhikari, the Leader of Opposition in the West Bengal Assembly, has written to the Enforcement Directorate (ED), alleging a financial scam in the..
IndiaTimes

Govt struggled to control talk of 'secret conspiracies' during COVID, inquiry hears

 The government has yet to deal with misinformation, according to Trade Secretary Kemi Badenoch, and struggled to stop some people from believing it during the..
Sky News

Foreign Minister of Seychelles arrives in India, set to meet EAM Jaishankar

 Seychelles Minister for Foreign Affairs and Tourism, Louis Sylvestre Radegonde, arrived in New Delhi for an official visit. Radegonde will meet with S Jaishankar..
IndiaTimes

​41 ambulances, 2 helicopters ready to ferry the rescued to hospital

 As hopes rise for the evacuation of 41 workers trapped in an under-construction tunnel in Uttarkashi's Silkyara, preparations are being made to transport them to..
IndiaTimes

Pfizer–BioNTech COVID-19 vaccine Pfizer–BioNTech COVID-19 vaccine Type of vaccine for humans

CDC Report Shows That 13.9% of US Adults Have Received an Updated COVID Vaccine [Video]

CDC Report Shows That 13.9% of US Adults Have Received an Updated COVID Vaccine

CDC Report Shows That , 13.9% of US Adults , Have Received an Updated COVID Vaccine. ABC reports that as of November 13, approximately 36 million adults in the United States have received an updated COVID-19 vaccine. According to new data from the Centers for Disease Control and Prevention, about 3.5 million children have also received an updated shot. . Compared to 2022, that figure is roughly equal to the number of Americans who received a bivalent booster by this time of the year. . ABC points out that the numbers mean that only 13.9% of adults in the U.S. have been vaccinated. In September, a poll conducted by the KFF COVID-19 Vaccine Monitor suggested that nearly twice as many adults said they planned to get the vaccine. According to that poll, 23% of adults said they were "definitely" planning on getting the updated booster, while another 23% said they would "probably" get one. The latest vaccine targets variants currently in circulation, which are an offshoot of the Omicron variant known as XBB. Both Pfizer-BioNTech and Moderna have formulations intended for people six months and older, while Novavax offers a dose for those over the age of 12. Both Pfizer-BioNTech and Moderna have formulations intended for people six months and older, while Novavax offers a dose for those over the age of 12. According to public health experts, people should receive respiratory virus vaccines by the end of October, but it's never too late. . This year's numbers, aligning more closely with pre-COVID patterns, indicate a reestablishment of typical 'cold and flu' season dynamics. However, we still have to see how the rest of the respiratory virus season plays out to know for sure, Dr. John Brownstein, epidemiologist and chief innovation officer at Boston Children's Hospital, via ABC

Credit: Wibbitz Top Stories    Duration: 01:30Published

Related news from verified sources

Moderna sues Pfizer, BioNTech over patent infringement of its Covid vaccine


newKerala.com - Published


Related videos from verified sources

Drs. Marik and McCullough on NewsMax: Moderna vs Pfizer Patent Lawsuit [Video]

Drs. Marik and McCullough on NewsMax: Moderna vs Pfizer Patent Lawsuit

Drs Paul Marik and Dr. Peter McCullough were guests on Wake Up America with Amanda Brilhante and Carl Higbie. They covered the news of the Moderna versus Pfizer patent lawsuit over the COVID-19..

Credit: Rumble     Duration: 05:20Published
Moderna sues Pfizer, BioNTech over COVID vaccine patent [Video]

Moderna sues Pfizer, BioNTech over COVID vaccine patent

Credit: Rumble     Duration: 04:06Published
Moderna Sues Pfizer Over Covid Vaccine The News [Video]

Moderna Sues Pfizer Over Covid Vaccine The News

Credit: Rumble     Duration: 00:49Published